Premenstrual asthma: The effect of estrogen on symptoms, pulmonary function, and β2-receptors

Pharmacotherapy

Volumn 17, Issue 2, 1997, Pages 224-234

  Chandler, Mary H H ^a   Schuldheisz, Sandra ^a   Phillips, Barbara A ^a   Muse, Ken N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; CYCLIC AMP; ESTRADIOL; GLUCOCORTICOID; NORADRENALIN; PROGESTERONE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; COUGHING; DRUG EFFECT; DYSPNEA; ESTROGEN THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HORMONE SUBSTITUTION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MENSTRUAL CYCLE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; SYMPTOMATOLOGY; TREATMENT OUTCOME; WHEEZING;

ADOLESCENT; ADULT; ASTHMA; BRONCHODILATOR AGENTS; CYCLIC AMP; ESTRADIOL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MENSTRUAL CYCLE; MIDDLE AGED; PREMENSTRUAL SYNDROME; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATORY FUNCTION TESTS; T-LYMPHOCYTES; TERBUTALINE;

EID: 0030901470     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Rees L. An aetiological study of premenstrual asthma. J Psychom Res 1963;7:1971-7.
2. Claude F, Allemany VR. Asthme et menstruation. Presse Med 1938;38:755-9.
3. Chiray M, Mollard H, Duret M. Asthme et perturbations des secretions hormonales de l'ovaire. Presse Med 1940;16:201-3.
4. Wulfsohn NL, Politzer WM. Bronchial asthma during menses and pregnancy. S Afr Med J 1964;38:173.
5. Aoyama Y, Toyoizumi K, Fueki R, Itoa A, Kobayashi S. Relation between bronchial asthma and the menstrual cycle. Jpn J Allergy 1965;14:583-9.
6. Hanley SP. Asthma variation with menstruation. Br J Dis Chest 1981;75:306-8.
7. Frank RT. The hormonal causes of pre-menstrual tension. Arch Neurol Psychiatry 1931;26:1053-7.
8. Enright T, Lim DT, Devnani R, Mariano R. Cyclical exacerbations of bronchial asthma. Ann Allergy 1987;58:405-6, 452-3.
9. Gibbs CJ, Coutts II, Lock R, Finnegan OC, White RJ. Premenstrual exacerbation of asthma. Thorax 1984;39:833-6.
10. Eliasson O, Densmore MJ, Scherzer HH, DeGraff AC. The effect of sodium meclofenamate in premenstrual asthma: a controlled clinical trial. J Allergy Clin Immunol 1987;79: 909-18.
11. Barkman RP. Sudden death in asthma [letter]. Med J Aust 1981;1:316-17.
12. Eliasson O, Scherzer HH, DeGraff AC. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol 1986;77:87-94.
13. Eliasson O, Scherzer HH. Recurrent respiratory failure in premenstrual asthma. Conn Med 1984;48:777-8.
14. Koullapis EN, Collins LNP. The concentration of 13,14-dihydro-15-OxO-prostaglandin F2alpha in peripheral venous plasma throughout the normal ovarian and menstrual cycle. Acta Endocrinol 1980;93:123-8.
15. Eliasson O, Long M, Dore-Duffy P, Densmore MJ, DeGraff AC. Serum 13-14-diOH-15-keto-prostaglandin F2alpha and airway response to meclofenamate and metaproterenol in relation to the menstrual cycle. J Asthma 1986;23:309-19.
16. Ozkaragoz K, Cakin F. The effect of menstruation on immediate skin reactions in patients with respiratory allergy. J Asthma Res 1970;7:171-5.
17. Foster PS, Goldie RG, Paterson JW. Effect of steroids on beta-adrenoceptor-mediated relaxation of pig bronchus. Br J Pharmacol 1983;78:441-5.
18. Lenoir RJ. Severe acute asthma and the menstrual cycle. Anaesthesia 1987;42:1287-90.
19. 1-selective adrenoceptor agonist. J Pharm Pharmacol 1981;33:353-6.
20. Moawad AH, River LP, Kilpatrick SJ. The effect of estrogen and progesterone on beta-adrenergic receptor activity in rabbit lung tissue. Am J Obstet Gynecol 1982;144:608-13.
21. Spicer LJ, Hammond JM. Effects of 2-hydroxyestradiol on the number of granulosa cell beta-adrenergic receptors. Endocrinology 1988;122:2710-17.
22. Wilkinson M, Herdon H, Pearce M, Wilson C. Radioligand binding studies on hypothalamic noradrenergic receptors during the estrous cycle or after steroid injection in ovariectomized rats. Brain Res 1979;168:652-5.
23. 3H]dihydroalprenolol binding and catecholamine stimulated cyclic AMP levels. Brain Res 1980;201:235-9.
24. Biegon A, Reches A, Snyder L, McEwen BS. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 1983;32:2015-21.
25. Skobeloff EM, Spivey WH, Silverman RA, Eskin BA, Harchelroad FP, Alessi TV. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996;156:1837-40.
26. Myers JR, Sherman CB. Should supplemental estrogens be used as steroid-sparing agents in asthmatic women? Chest 1994;106:318-19.
27. American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis 1991;144:1202-18.
28. Anonymous. 1983 Metropolitan height and weight tables. Stat Bull 1983;Jan-June:2-9.
29. Chandler MHH, Clifton GD, Louis BA, Coons SJ, Foster TS, Phillips BA. Home monitoring of theophylline levels: a novel therapeutic approach. Pharmacotherapy 1990;10:294-300.
30. Bouloux P, Perrett D, Besser GM. Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection. Ann Clin Biochem 1985;22:194-203.
31. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85:751-8.
32. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968;21:77-89.
33. Roszman TL, Brooks WH. Immunobiology of primary intracranial tumors. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumors. Clin Exp Immunol 1980;39:395-402.
34. Rutledge DR, Wallace A, Melchior W, Touchette M. Racial differences in baseline cyclic adenosine monophosphate concentrations per million T lymphocytes and protein concentrations. Ther Drug Monit 1990;12:541-6.
35. 2-adrenergic receptor responsiveness in young and elderly asthmatics. Pharmacotherapy 1992;12:376-82.
36. Snedecor GW, Cochran WG. Statistical methods. Ames, IA: Iowa State University Press, 1978:385-8.
37. Juniper EF, Kline PA, Roberts RS, Hargreave FE, Daniel EE. Airway responsiveness to methacholine during the natural menstrual cycle and effect of oral contraceptives. Am Rev Respir Dis 1987;135:1039-42.
38. Pauli BD, Reid RL, Munt PW, Wigle RD, Forkert L. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis 1989;140:358-62.
39. Weinmann GG, Zacur H, Fish J. Absence of premenstrual increase in airway responsiveness in asthmatic women [abstr]. Am Rev Respir Dis 1985;131:A5.
40. 2-adrenergic receptors and receptor coupling to adenylate cyclase in human mononuclear leukocytes and platelets in relation to physiological variations of sex steroids. J Clin Endocrinol Metab 1984;58:1068-76.
41. 2-adrenoceptor density during menstrual cycle and pregnancy, in delivery and puerperium. Eur J Obstet Gynecol Reprod Biol 1990;34:79-87.
42. Lieberman D, Kopernic G, Porath A, Levitas E, Lazer S, Heimer D. Influence of estrogen replacement therapy on airway reactivity. Respiration 1995;62:205-8.
43. Villa MP, Bernardi M, Tura A, et al. Bronchial reactivity and sex hormone: study in a Turner's population. Pediatr Pulmonol 1990;9:199-205.
44. Collins LC, Peiris A. Bronchospasm secondary to replacement estrogen therapy. Chest 1993;104:1300-2.
45. Troisi RJ, Speizer FE, Willett WC, Trichopoulos D, Rosner B. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma: a prospective cohort study. Am J Respir Crit Care Med 1995;152:1183-8.
46. 2-receptors during smoking cessation in patients with chronic obstructive pulmonary disease. Pharmacotherapy 1994;14:162-72.
47. 2-adrenoceptors during the menstrual cycle. Br J Clin Pharmacol 1994;37:583-8.
48. 2-responses to intravenous salbutamol during the menstrual cycle. Eur J Clin Pharmacol 1994;46:511-15.
49. Baumann G. Estrogen and the hypothalamic-pituitary-adrenal axis in man: evidence for normal feedback regulation by corticosteroids. J Clin Endocrinol Metab 1983;57:1193-7.
50. Josefsson E, Tarkowski A, Carlsten H. Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol 1992;142:67-78.
51. Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen? Circulation 1995;92:5-8.
52. Coutts II, White RJ. Asthma in pregnancy. J Asthma 1991;28:433-6.
53. Beynon HLC, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1988;2:370-2.